These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38868465)

  • 1. The effect of lemborexant on insomnia in patients with psychiatric disorders: Detailed evaluation using the Athens Insomnia Scale.
    Murayama T; Ito Y; Narita K; Ishida T; Hinotsu S; Fujita M
    PCN Rep; 2024 Mar; 3(1):e165. PubMed ID: 38868465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder.
    Arnold V; Ancoli-Israel S; Dang-Vu TT; Mishima K; Pinner K; Malhotra M; Moline M
    Neurol Ther; 2024 Aug; 13(4):1081-1098. PubMed ID: 38748321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of patients who were able to switch from benzodiazepine hypnotics to lemborexant.
    Suzuki H; Hibino H
    SAGE Open Med; 2021; 9():20503121211037903. PubMed ID: 34394934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of lemborexant for insomnia disorder.
    Suzuki H; Hibino H
    SAGE Open Med; 2021; 9():20503121211039098. PubMed ID: 34422270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma-aminobutyric acid-benzodiazepine receptor agonists or suvorexant.
    Okino K; Suzuki H; Tomioka H; Sanada K; Kawai K; Iwanami A; Inamoto A
    Hum Psychopharmacol; 2023 May; 38(3):e2868. PubMed ID: 36960814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Transitioning to Lemborexant from Z-drug, Suvorexant, and Ramelteon in Japanese Insomnia Patients: An Open-label, Multicenter Study.
    Ozone M; Hirota S; Ariyoshi Y; Hayashida K; Ikegami A; Habukawa M; Ohshima H; Harada D; Hiejima H; Kotorii N; Murotani K; Taninaga T; Uchimura N
    Adv Ther; 2024 Apr; 41(4):1728-1745. PubMed ID: 38460107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists.
    Tachibana M; Kanahara N; Oda Y; Hasegawa T; Kimura A; Iyo M
    J Clin Sleep Med; 2024 Apr; 20(4):603-613. PubMed ID: 38063235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching to lemborexant for the management of insomnia in mental disorders: the SLIM study.
    Horikoshi S; Miura I; Suzuki Y; Kobayashi Y; Hirata Y; Goto M; Ichinose M; Yamamoto S; Kanno-Nozaki K; Watanabe K; Yabe H
    J Clin Sleep Med; 2023 Oct; 19(10):1753-1758. PubMed ID: 37243798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of lemborexant over 12 months in Asian adults with insomnia disorder.
    Dash A; Pinner K; Inoue Y; Hayashida K; Lim SC; Yun CH; Lan TH; Huang CL; Yardley J; Kubota N; Moline M
    Sleep Med X; 2022 Dec; 4():100044. PubMed ID: 35402894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of sleep and pain with lemborexant administration in patients with chronic pain: a retrospective observational study.
    Ueno K; Sato H; Nomura Y; Obata N; Mizobuchi S
    Pain Med; 2024 Feb; 25(2):139-143. PubMed ID: 37707540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapies for sleep disturbances in dementia.
    McCleery J; Sharpley AL
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009178. PubMed ID: 33189083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lemborexant, an orexin receptor antagonist sedative-hypnotic: Is it useful for insomnia in psychiatric disorders?
    Keks NA; Hope J
    Australas Psychiatry; 2022 Aug; 30(4):530-532. PubMed ID: 35491942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act.
    Moline M; Asakura S; Beuckman C; Landry I; Setnik B; Ashworth J; Henningfield JE
    Psychopharmacology (Berl); 2023 Apr; 240(4):699-711. PubMed ID: 36749354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitioning insomnia patients from zolpidem to lemborexant: A multicenter, open-label study evaluating a next-dose transition approach to insomnia pharmacotherapy.
    Ahmad M; Kelly J; Montano CB; Kumar D; Perdomo C; Malhotra M; Amchin J; Moline M
    Sleep Med X; 2024 Dec; 7():100098. PubMed ID: 38312371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the Efficacy and Safety of Lemborexant, a Dual Receptor Orexin Antagonist (DORA), in the Treatment of Adults With Insomnia Disorder.
    Waters K
    Ann Pharmacother; 2022 Feb; 56(2):213-221. PubMed ID: 34078141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in fatigue and sleep measures with the dual orexin receptor antagonist lemborexant in adults with insomnia disorder.
    Chepke C; Jain R; Rosenberg R; Moline M; Yardley J; Pinner K; Kumar D; Perdomo C; Filippov G; Atkins N; Malhotra M
    Postgrad Med; 2022 Apr; 134(3):316-325. PubMed ID: 35254948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of lemborexant in midlife women with insomnia disorder.
    Terauchi M; Cheng JY; Yardley J; Pinner K; Moline M; Malhotra M; Inabe K; Nishida M; Pappadopulos E
    Menopause; 2023 Aug; 30(8):839-848. PubMed ID: 37339396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of lemborexant 5 mg versus 10 mg for the treatment of insomnia: a systematic review.
    Habiba U; Waseem R; Shaikh TG; Waseem S; Ahmed SH; Asghar MS
    Neurol Sci; 2023 May; 44(5):1533-1541. PubMed ID: 36633778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2.
    Kärppä M; Yardley J; Pinner K; Filippov G; Zammit G; Moline M; Perdomo C; Inoue Y; Ishikawa K; Kubota N
    Sleep; 2020 Sep; 43(9):. PubMed ID: 32585700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zolpidem: Efficacy and Side Effects for Insomnia.
    Edinoff AN; Wu N; Ghaffar YT; Prejean R; Gremillion R; Cogburn M; Chami AA; Kaye AM; Kaye AD
    Health Psychol Res; 2021; 9(1):24927. PubMed ID: 34746488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.